GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA

Company Summary

The company GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA is a Joint Stock Company, established in Thursday, November 4, 2004, with headquarters in the municipality of LISBOA. The share capital is 250.000,00 € , and its Economic Activity Code (CNAE) is 86911 Clinical laboratory services activities
In the sector corresponding to this CAE with an average EBITDA of 41.205,95 € (profit before depreciation, amortization, financing expenses and taxes).
The average payment term recorded in this sector was 98 days.

Status from Genomed, Diagnosticos de Medicina Molecular Sa

Active

Sales Evolution in the Company

Ascending

Commercial Incidents

Legal Actions (Defendant/Plaintiff)

Tax Authority Debts

Social Security Debts

Insolvencies

Public Execution List

Profile Report - 15€
Available Balance Sheets

2023, 2022, 2021

Financial Report 27€

Company reports Genomed, Diagnosticos de Medicina Molecular Sa